Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization GlobeNewswire - Mon Dec 9, 7:42AM CST CMTX - Mon Dec 9, 7:42AM CST
The Syneos Health Insights Hub, a dynamic destination for what's next thinking and future-focused insights, today released 2020 Health Trends: Changing Lives and Life Sciences. This annual trends report...
Working and Rallying Jim Giaquinto - Zacks Investment Research - Mon Dec 9, 12:15AM CST Jim Giaquinto - ZACKS - Mon Dec 9, 12:15AM CST
Working and Rallying
SYNH vs. HMSY: Which Stock Should Value Investors Buy Now? Zacks Equity Research - Zacks Investment Research - Mon Dec 2, 8:30AM CST Zacks Equity Research - ZACKS - Mon Dec 2, 8:30AM CST
SYNH vs. HMSY: Which Stock Is the Better Value Option?
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement GlobeNewswire - Thu Nov 21, 8:02AM CST CMTX - Thu Nov 21, 8:02AM CST
Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released "Real World Value: Advancing Payer Understanding of RWE in Rare Disease," a report identifying...
Is Syneos Health (SYNH) a Great Value Stock Right Now? Zacks Equity Research - Zacks Investment Research - Wed Nov 20, 8:10AM CST Zacks Equity Research - ZACKS - Wed Nov 20, 8:10AM CST
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
Syneos Health Collaborates with AiCure for Patient Engagement Zacks Equity Research - Zacks Investment Research - Wed Nov 13, 2:39PM CST Zacks Equity Research - ZACKS - Wed Nov 13, 2:39PM CST
Syneos Health (SYNH) aims to optimize patient engagement and trial success by partnering with AiCure.
Syneos Health to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire - Wed Nov 13, 7:00AM CST CMTX - Wed Nov 13, 7:00AM CST
Syneos Health(R) (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...
Bernadette Connaughton Appointed to Syneos Health Board of Directors GlobeNewswire - Tue Nov 12, 3:30PM CST CMTX - Tue Nov 12, 3:30PM CST
Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and a Contract Commercial Organization (CCO), today announced the appointment...
Syneos Health and AiCure Announce Partnership to Optimize Patient Engagement and Trial Success GlobeNewswire - Tue Nov 12, 8:19AM CST CMTX - Tue Nov 12, 8:19AM CST
Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and AiCure, an AI and advanced data analytics company, today announced a novel strategic partnership to...
SYNH vs. OMCL: Which Stock Should Value Investors Buy Now? Zacks Equity Research - Zacks Investment Research - Tue Nov 5, 8:30AM CST Zacks Equity Research - ZACKS - Tue Nov 5, 8:30AM CST
SYNH vs. OMCL: Which Stock Is the Better Value Option?
Syneos Health (SYNH) Tops Q3 Earnings Estimates, Ups EPS View Zacks Equity Research - Zacks Investment Research - Fri Nov 1, 9:26AM CDT Zacks Equity Research - ZACKS - Fri Nov 1, 9:26AM CDT
Syneos Health (SYNH) exhibits robust topline performance in the third quarter, backed by strong segmental growth.
Syneos Health (SYNH) Surpasses Q3 Earnings Estimates Zacks Equity Research - Zacks Investment Research - Thu Oct 31, 6:35AM CDT Zacks Equity Research - ZACKS - Thu Oct 31, 6:35AM CDT
Syneos Health (SYNH) delivered earnings and revenue surprises of 4.82% and -0.44%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Syneos Health Reports Third Quarter 2019 Results GlobeNewswire - Thu Oct 31, 5:16AM CDT CMTX - Thu Oct 31, 5:16AM CDT
Highlights
Syneos Health, Inc. to Host Earnings Call ACCESSWIRE - Thu Oct 31, 5:04AM CDT CMTX - Thu Oct 31, 5:04AM CDT
NEW YORK, NY / ACCESSWIRE / October 31, 2019 / Syneos Health, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on October 31, 2019 at 8:00 AM Eastern...
ResMed's (RMD) Q1 Earnings Beat Estimates, Margins Expand Zacks Equity Research - Zacks Investment Research - Fri Oct 25, 10:23AM CDT Zacks Equity Research - ZACKS - Fri Oct 25, 10:23AM CDT
ResMed (RMD) registers growth at CER across its key operating segments in Q1.
Integra LifeSciences' (IART) Earnings Top Estimates in Q3 Zacks Equity Research - Zacks Investment Research - Fri Oct 25, 9:27AM CDT Zacks Equity Research - ZACKS - Fri Oct 25, 9:27AM CDT
We are upbeat about the year-over-year revenue growth in Integra LifeSciences' (IART) Codman Specialty Surgical segment.
Edwards Lifesciences (EW) Beats on Q3 Earnings, Ups EPS View Zacks Equity Research - Zacks Investment Research - Thu Oct 24, 8:53AM CDT Zacks Equity Research - ZACKS - Thu Oct 24, 8:53AM CDT
Edwards Lifesciences (EW) reports strong Q3 sales on the recent FDA indication expansion of SAPIEN 3 and SAPIEN 3 Ultra systems.
Varian (VAR) Earnings and Revenues Surpass Estimates in Q4 Zacks Equity Research - Zacks Investment Research - Thu Oct 24, 8:10AM CDT Zacks Equity Research - ZACKS - Thu Oct 24, 8:10AM CDT
Varian (VAR) gains from core Oncology segment's solid contribution in fiscal Q4.
Align Technology (ALGN) Beats on Q3 Earnings, Margins Fall Zacks Equity Research - Zacks Investment Research - Thu Oct 24, 6:38AM CDT Zacks Equity Research - ZACKS - Thu Oct 24, 6:38AM CDT
We are upbeat about Align Technology (ALGN) witnessing continued momentum in Invisalign volumes across all geographies
Boston Scientific (BSX) Beats on Q3 Earnings, Tapers EPS View Zacks Equity Research - Zacks Investment Research - Wed Oct 23, 8:49AM CDT Zacks Equity Research - ZACKS - Wed Oct 23, 8:49AM CDT
Boston Scientific (BSX) is making an all-out effort to solidify its core businesses and invest in the new technologies as well as the global markets. This reflects on the sales uptick in Q3.
